Rationale. The Brisbane Cardiac Consortium, a quality improvement collaboration of clinicians from three hospitals and Wve divisions of general practice, developed and reported clinical indicators as measures of the quality of care received by patients with acute coronary syndromes or congestive heart failure.
Project rationale and conception
Improving quality of health care requires performance measurement and feedback. Various programmes targeting cardiac care have combined the use of clinical indicators with other quality improvement interventions in identifying and closing the gaps between routine care and evidence-based best practice [1] [2] [3] [4] .
However, in the successful development and use of clinical indicators, several dimensions need to be carefully considered:
(i) deWning the purpose of measurement; (ii) determining target standards of care; (iii) formulating data collection methods; (iv) converting data into usable clinical indicators; and (v) maximizing the impact of indicator feedback. In this report we describe our experience in undertaking these steps within a multifaceted quality improvement programme targeting in-hospital and post-hospital care of patients admitted with acute coronary syndromes (ACS) or congestive heart failure (CHF). An overview of our programme is provided in Box 1.
Development and design of clinical indicators Defining the purpose of measurement
We wanted indicators that would guide and motivate internal quality improvement activities in hospital and general practice, and not be used merely for monitoring purposes by external agencies. To engage health care providers we wanted our indicators to be clinically relevant to speciWc processes of care that demonstrated an accepted link with desired health outcomes [5] . We aimed to present aggregate indicator data at the level of facility or, where sample size was large enough, at a departmental or group general practice level. As the target groups were identiWable groups of clinicians, we considered it vital that the indicators were robustly accurate.
Determining standards and indicators using multidisciplinary teams
We speciWed the target standards of care in a set of clinical practice guideline recommendations derived from a systematic review of the research evidence [6] [7] [8] . These guidelines were developed over a period of 5 months, using formal group consensus methods, by multidisciplinary panels of general physicians (n = 5), cardiologists (n = 5), general practitioners (GPs; n = 12), clinical pharmacists (n = 2), and advanced physician trainees (n = 3). These panels contained expertise in clinical content and measurement, and represented the interests of potential users of the indicators [9] . The development work was coordinated by the programme manager in liaison with the eight-member Clinical Guideline Working Group.
The same multidisciplinary team derived sets of clinical indicators from guideline recommendations and a review of indicators published by other groups [10, 11] . Indicators related to both process (what care was given to whom) and outcome (what was the end result of care), were designed to be as explicit and objective as possible, and were developed by group consensus.
Methods

Data collection
Data used to calculate in-hospital care indicators were abstracted by trained nurses from hospital medical records retrieved shortly after discharge. Post-hospital care data were collected using a 1-page heart-check form completed during GP consultations at 3, 6, and 12 months post-discharge. Examples of data forms used are provided in supplementary data. We restricted data elements for each indicator to those that were objectively veriWable and easily retrieved from medical records or GP case notes.
Conversion of data into useful clinical indicators
Improving care processes known to have a direct link with health outcomes was our prime objective. To this end, process indicators predominated over outcome indicators, particularly
Box 1 Overview of the Brisbane Cardiac Consortium
The Brisbane Cardiac Consortium (BCC) was one of four quality improvement consortia in Australia to receive 2 years funding from the federal government under the Clinical Support Systems Program (CSSP) auspiced by the Royal Australian College of Physicians. The program targeted the in-hospital and post-hospital care of patients admitted with acute coronary syndromes (ACS) and congestive heart failure (CHF). The program ran from October 1, 2000, to August 31, 2002 , and involved three teaching hospitals [Royal Brisbane (800 beds), Princess Alexandra (700 beds) and Queen Elizabeth II Hospitals (260 beds)] and four Divisions of General Practice within metropolitan Brisbane. Program objectives were to optimize care using systematic processes of performance measurement and feedback combined with various quality improvement interventions. The latter included dissemination of locally developed clinical practice guidelines and other forms of decision support, academic detailing of patients and clinicians by clinical pharmacists, provision of patient self-management resources, and close liaison between hospital and general practitioners and community pharmacists regarding future patient management. Primary outcome measures were changes in clinical indicators between baseline (1/10/00-17/4/01) and post-intervention (15/3/02-30/8/02) periods as measured on all consecutive patients who met pre-speciWed case deWnitions.* Post-hospital care indicators were collected on a subset of patients who satisWed eligibility criteria** and gave informed consent to posthospital follow-up. The program saw participation of 2495 patients (1584 with ACS; 911 with CHF), 10 cardiologists, 17 general physicians, 20 emergency physicians, 5 clinical pharmacists, 50 medical registrars, 200 residents, 150 nursing staff, and 1020 general practitioners.
*ACS: clinical diagnosis of ACS + elevation of cardiac enzyme markers (troponin or creatine kinase levels elevated to more than 1.5 and 2.0 times upper normal reference range respectively). CHF: clinical diagnosis and at least 3 key clinical signs (elevated jugular venous pressure, gallop rhythm, chest crackles to mid-zones bilaterally, pedal oedema, or pulmonary oedema or cardiomegaly on chest X-ray). **Absence of major co-morbidity (physical or psychological) which precluded ability to self-care, permanent resident in the greater Brisbane area, community-living, and ability to speak English.
as large, risk-adjusted samples are required to detect signiWcant changes in outcome indicators (such as in-hospital death or 30-day readmission) given their relatively low event rates (in our experience <15%) [12] .
We routinely gave clinicians information on 28 in-hospital and 12 post-hospital process indicators: 13 and six for ACS, and 15 and six for CHF, respectively (see Tables 1 and 2 ). We wanted our process indicators to accurately discriminate between eligible patients who should receive interventions (sensitivity) and ineligible patients who should not (speciWcity) [13] .
We calculated each indicator as a proportion. In-hospital process indicators comprised the number of eligible patients actually receiving the intervention (numerator) over the number of patients eligible to receive it (denominator). Eligibility for each intervention was assessed as deWnite indication with no relative or absolute contra-indications as ascertained from hospital records. In contrast, post-discharge indicators were simply rates of overall prescription of drugs or non-drug interventions among all evaluable patients that had consented to follow-up and had been reviewed by GPs. This more simple format was deliberately designed to reduce the opportunity costs to GPs of collecting more detailed data about patient eligibility. Outcome indicators for in-hospital care comprised in-hospital death, 30-day same-cause readmission rate, and median length of stay. No outcome indicators for post-hospital care were included.
We sought to make our indicators credible and capable of eliciting clinician responses by maximizing the following attributes.
Relevance. Our process indicators were locally agreed, evidencebased, and important to both patients and clinicians [14] .
Reliability. We minimized measurement error due to variations in sampling, data collection, or analysis [15] using strategies listed in Table 3 . Potential for error in collection of postdischarge data by GPs was minimized by use of a 1-page form containing straightforward instructions and that allowed attachment of printouts of tests and medications from the GP's electronic records. Accuracy of discharge medications was conWrmed by cross-checking information on the in-hospital and GP forms with that recorded in pharmacy databases.
Re-abstraction audits of 5% of randomly chosen hospital records found the level of agreement between data abstracters and principal investigators to be high: kappa scores were 1.0 for case deWnition and ≥0.7 for all other items. The accuracy of GP-returned forms could not be veriWed as GP case notes were inaccessible to independent reviewers. However, scrutiny of returned forms conWrmed entries in >70% of all data Welds, with 95% completion for medication use.
Validity. We validated in-hospital process indicators by independently reviewing charts of all seemingly eligible patients who failed to receive speciWc interventions in the Wrst and last 6-month periods for those indicators that showed a failure rate of >20% (see below). The only indicator for which clinically legitimate reasons were detected for withholding care in >5% of indicator-failed cases was prescription of warfarin in patients with CHF. In 64 of 113 (56%) patients deemed eligible for warfarin but who did not receive this drug, review disclosed relative contra-indications such as 'frailty' or 'risk of falls' in 43 (67%) of cases.
Impact. To inXuence clinician behaviour, we chose indicators that had the capacity to signal the existence of important evidence-practice gaps and that were potentially amenable to change [16, 17] . We presented indicator values in easy to interpret graphical and tabular formats, which depicted changes in indicator rates over time ( Figures 1 and 2 ) and which included a reference standard (or target) of 100% of highly eligible patients receiving the stated intervention. In addition, we employed various strategies (see below) to enhance the ability of indicator feedback to stimulate clinician attempts to improve care [18, 19] .
Maximization of clinical indicator impact
Feedback of in-hospital care indicators occurred at 6-monthly intervals, while feedback of post-discharge (general practice) indicators occurred over two rounds separated by 18 months, as follow-up data were collected more slowly and the patient sample was only one-third that of the in-hospital sample.
Dissemination
We disseminated results via hospital unit meetings, hospital and divisions of general practice newsletters, drug and therapeutics bulletins, grand round presentations, educational meetings, and in-service training sessions. We ensured doctors, nurses, and clinical pharmacists at all levels were exposed to indicator feedback [20] .
Feedback partnered with education and discussion
Clinical audit and periodic feedback, in isolation, engender only moderate levels of change [21] . Lack of skills, knowledge, and leadership are some of the known barriers to practice improvement [22] . Consequently, we coupled indicator feedback in hospitals with small group discussions about guideline recommendations and the signiWcance of the indicator Wndings. Practice improvement was promoted through citing case studies of successful innovation elsewhere, and the formation of interdisciplinary groups that took responsibility for improving speciWc care processes [23] .
Customized indicator analyses
Encouraged by the work of others [17] , and receiving local requests, we provided more personalized reports to individual hospital consultants about performance within his or her unit if patient samples were large enough to give statistically meaningful trends. These reports compared that consultant's performance with peers from all three hospitals and included patient demographics to reconcile any differences in case mix.
Feedback from providers and modifications to the original plan
Clinician responses to reported indicators in the Wrst feedback round centred, not surprisingly, on data quality and face validity, The rigorous research approach to measurement can appear at odds with the more pragmatic process of measurement for improvement [24] . Clinicians experiencing difWculty in accepting indicator feedback were invited to review the records of their indicator-failed patients. Only four clinicians accepted this offer and none asked for the reported indicators to be revised.
In the second round we emphasized indicators for which improvement in care would result in the greatest gains in ................................................................................................................................................ 
All patients Nil
Clinic follow-up: proportion of patients scheduled for outpatient clinic review within 4 weeks of discharge All patients Nil patient outcome. We offered potential solutions based on literature reviews and action research conducted elsewhere. We collaborated with various groups in providing more customized data that better informed their attempts to improve care. This support-giving approach was further consolidated in the third round of feedback, by which time data quality was no longer an issue. Various multidisciplinary groups were now acting across professional boundaries to improve speciWc aspects of care [23] . At this time, we surveyed a representative sample (n = 150) of hospital clinicians about the usefulness and impact of indicator feedback. Although the response rate was low (25%), >70% of respondents found feedback useful and wished to continue receiving it, while 52% reported that it had resulted in changes to practice.
During the course of our implementation, we modiWed the project design as a result of clinician feedback and internal re-appraisal.
Brevity and clarity. Our Wrst post-discharge care feedback newsletter to GPs met with almost universal dismissal on the grounds that it contained too much uninterpretable data that could not be assimilated by busy practitioners. Consequently we restricted ourselves to simple tables and boxed key messages (see Figure 3) , which elicited positive responses.
Liberalization of eligibility criteria. With certain pharmacological indicators (e.g. warfarin, ACE inhibitors) we found that by using restricted indications and inclusive contra-indications, very few patients demonstrated eligibility for treatment, and thus the indicator was rendered useless. In such cases we created, by consensus, a new version of the indicator with more liberal eligibility criteria that still accorded with evidencebased clinical decision-making.
Balancing effort of validation with the need for timely feedback. We found that repeated minor corrections of the raw data aimed at maximizing validity of the calculated indicator did not make any signiWcant difference to the reported indicator value, and simply delayed its timely release which, in turn, reduced its impact on clinicians. We reconWrmed Hannan's dictum: 'do not wait for better data-perfect should not be the enemy of good' [25] . Train data collectors in the use of standardized datasheets to collect information using data entry manual Minimize errors in database design and reporting through regular communication between clinicians, data managers, and statisticians Develop database logic checks to alert when incorrect data are being entered, e.g. discharge date that is before an admission date Pilot test the indicators and data collection methods and reWne them over a set period (in our case, 3 months) and update data entry manual accordingly Monitor data reliability with frequent interim analyses and regular meetings of data collectors to ensure consistency of data item interpretation and measurement Undertake re-abstraction audits of randomly selected hospital charts in assessing level of agreement among abstracters (inter-rater reliability)
Avoiding frequent minor changes in indicator deWnition [26] . While data sets should allow for changes in indicator deWnitions to reXect evidence-based changes in practice, minor changes served only to confuse clinicians wanting to make comparisons across feedback periods. We ceased making different versions of the same indicators after the Wrst round for reasons other than those mandated by the publication of results of important, new clinical trials.
Discontinuation of indicator reports based on small samples. We originally envisaged a 3-month rather than a 6-month cycle for inhospital feedback. While we desired timely indicator feedback, the shorter cycle span led to smaller patient samples which, for some indicators with low event rates, introduced excess random error [27] . While statistical process control methods [28, 29] could have been used to correct for such error, we were concerned that adding such analyses to our feedback formats would have jeopardized their interpretability to the majority of clinicians.
Discontinuation of formal feedback sessions. By the third round of feedback, hospital clinicians did not desire feedback to be accompanied by formal discussion sessions, suggesting that external facilitation becomes redundant once the culture of improvement has been established.
Results
Preliminary results
Baseline process indicators suggested suboptimal performance in several areas [30, 31] , with subsequent improvement in most indicators and signiWcant change in 17 of 40 (Tables 4-7) . It is impossible to gauge the extent to which these improvements in care can be attributed solely to clinical indicator feedback among several concurrent quality improvement interventions. However, focus group discussions and results of the previously mentioned questionnaire survey suggested that indicator feedback had stimulated changes in practice.
Lessons learned and future plans
Our experience yielded several lessons that are guiding future plans. Firstly, keep the number of data elements to a minimum. Our dataset for in-hospital care comprised 171 variables for ACS and 204 for CHF, many relating to patient demographics and clinical characteristics, which we reasoned were relevant to determining process-of-care eligibility or conducting risk-adjusted outcome comparisons. In retrospect, a large fraction of these data (and the effort involved in collecting them) added little to the validity of reported indicators and was not required for case-mix adjustment in the presence of case deWnitions and standardized patient ascertainment. In a further extension of our work, data elements have been reduced to 50 for ACS and 45 for CHF [32] . Secondly, more economical methods of data collection and entry are worth exploring. In the absence of universal electronic medical records, proformas that are read by text recognition software are being trialed [33] , which affords more rapid importation of data into databases and reduction in transcription errors. Thirdly, in terms of sustainability, our costings suggest that measurement and feedback systems used ∼50% (or $500 000) of the programme budget, which was expended on 2500 patients (i.e. approximately $200 per patient). Trends in the data suggest that costs are more than likely to be offset by improvements in health outcomes such as the observed 1-day reduction in median length of hospital stay for patients with ACS. The minimization of datasets and the use of previously mentioned scanning technology will signiWcantly reduce this infrastructure cost.
In the Queensland state public hospital system, our revised methods for measuring and reporting clinical indicator data are being continued in the three consortium hospitals and extended to 14 other large hospitals under the auspices of the Cardiac Collaborative of the Queensland Health Collaborative for Healthcare Improvement [32] . Our indicator experience is also assisting the Cardiac Society of Australia and New Zealand (CSANZ) [34] and the National Institute of Clinical Studies (NICS) [35] to develop national indicator sets for ACS and CHF, respectively, and to inform the quality improvement strategies that these organizations may want to sponsor in the future.
As a result of our programme, Wve divisions of general practice representing all GPs in metropolitan Brisbane have become involved in clinical audit and feedback. However, the long-term continuation of this activity in its current form is proving to be a challenge due to the expense and labour involved. Less than ideal response rates limit the sample size, requiring longer feedback cycles in order to accrue meaningful data.
Performance measurement and feedback are an integral part of quality improvement initiatives. We attempted to develop a sustainable system of indicator collection and reporting as part of a programme targeting care of two common cardiac conditions associated with signiWcant mortality and morbidity. Taking a patient-centred focus, we provided feedback for indicators targeting both hospital and community providers. At an organizational level, our methodology is being extended to multiple public hospitals throughout our state, while the smaller, less resourced divisions of general practice are building on their experience to develop lower cost systems for ongoing clinical audit. Table 7 Changes in process indicators for post-hospital care (congestive heart failure) 1 SigniWcant change (P ≤ 0.05). 
ACE inhibitor
